Michael A Mussallem Edwards Lifesciences Corp (EW) insider trading activity

Michael A Mussallem is Director of Edwards Lifesciences Corp. Currently has a direct ownership of 4,485 shares of EW, which is worth approximately $302,916. The most recent transaction as insider was on Feb 15, 2022, when has been sold 12,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.49K

0% 3M change

0% 12M change

Total Value Held $302,916

MICHAEL A MUSSALLEM Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 15 2022	SELL Bona fide gift	-	12,500 Reduced 10.64%	105,027 Common Stock
Feb 15 2022	SELL Open market or private sale	$3,589,288 $110.27 p/Share	32,550 Reduced 29.11%	79,271 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 26.6%	124,321 Common Stock
Jan 06 2022	SELL Bona fide gift	-	12,500 Reduced 5.37%	220,251 Common Stock
Jan 06 2022	SELL Open market or private sale	$4,048,244 $124.37 p/Share	32,550 Reduced 14.76%	188,001 Common Stock
Jan 06 2022	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 16.2%	233,051 Common Stock
Dec 20 2021	SELL Open market or private sale	$3,882,564 $119.28 p/Share	32,550 Reduced 14.76%	188,001 Common Stock
Dec 20 2021	SELL Bona fide gift	-	12,500 Reduced 5.52%	214,025 Common Stock
Dec 20 2021	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 16.2%	233,051 Common Stock
Nov 09 2021	SELL Bona fide gift	-	12,500 Reduced 5.36%	220,551 Common Stock
Nov 09 2021	SELL Open market or private sale	$3,903,722 $119.93 p/Share	32,550 Reduced 14.76%	188,001 Common Stock
Nov 09 2021	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 16.2%	233,051 Common Stock
Oct 01 2021	SELL Open market or private sale	$3,652,110 $112.2 p/Share	32,550 Reduced 14.76%	188,001 Common Stock
Oct 01 2021	SELL Bona fide gift	-	12,500 Reduced 5.37%	220,251 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 16.2%	233,051 Common Stock
Sep 15 2021	SELL Open market or private sale	$3,935,621 $120.91 p/Share	32,550 Reduced 14.76%	188,001 Common Stock
Sep 15 2021	SELL Bona fide gift	-	12,500 Reduced 5.48%	215,568 Common Stock
Sep 15 2021	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 16.2%	233,051 Common Stock
Aug 03 2021	SELL Bona fide gift	-	12,500 Reduced 5.36%	220,551 Common Stock
Aug 03 2021	SELL Open market or private sale	$3,714,281 $114.11 p/Share	32,550 Reduced 14.76%	188,001 Common Stock
Aug 03 2021	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 16.2%	233,051 Common Stock
Jul 01 2021	SELL Bona fide gift	-	12,500 Reduced 5.36%	220,551 Common Stock
Jul 01 2021	SELL Open market or private sale	$3,405,056 $104.61 p/Share	32,550 Reduced 14.76%	188,001 Common Stock
Jul 01 2021	BUY Exercise of conversion of derivative security	$980,288 $21.76 p/Share	45,050 Added 16.2%	233,051 Common Stock
Jun 09 2021	SELL Bona fide gift	-	12,500 Reduced 5.36%	220,551 Common Stock

MAM

Michael A Mussallem

Director

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account